This isn't anything new most of us don't know, but the word is getting out more and more. This is a targeted oncology site...not a pump site. Mentions nothing about the stock at all, only cytodyns latest PR and the clinical information about the phase 1b/2 trial...guessing its a site geared more towards physicians/oncologists/sciency people, not layperson investor type people like myself.


https://www.targetedonc.com/news/leronlimab-m...mtnbc-data